These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 31128154)
41. Clinical aspects and biological bases of drug-resistant epilepsies. Regesta G; Tanganelli P Epilepsy Res; 1999 Apr; 34(2-3):109-22. PubMed ID: 10210025 [TBL] [Abstract][Full Text] [Related]
42. Antiepileptic Drug Treatment of Epilepsy in Children. Moosa ANV Continuum (Minneap Minn); 2019 Apr; 25(2):381-407. PubMed ID: 30921015 [TBL] [Abstract][Full Text] [Related]
43. The antiepileptic potential of nucleosides. Kovács Z; Kékesi KA; Juhász G; Dobolyi Á Curr Med Chem; 2014; 21(6):788-821. PubMed ID: 24251559 [TBL] [Abstract][Full Text] [Related]
44. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Perucca E; French J; Bialer M Lancet Neurol; 2007 Sep; 6(9):793-804. PubMed ID: 17706563 [TBL] [Abstract][Full Text] [Related]
45. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473 [TBL] [Abstract][Full Text] [Related]
46. Cannabis and Endocannabinoid Signaling in Epilepsy. Katona I Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165 [TBL] [Abstract][Full Text] [Related]
47. Aggravation of epilepsy by anti-epileptic drugs. Gayatri NA; Livingston JH Dev Med Child Neurol; 2006 May; 48(5):394-8. PubMed ID: 16608550 [TBL] [Abstract][Full Text] [Related]
48. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Remy S; Beck H Brain; 2006 Jan; 129(Pt 1):18-35. PubMed ID: 16317026 [TBL] [Abstract][Full Text] [Related]
49. The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs. Navarrete-Modesto V; Orozco-Suárez S; Feria-Romero IA; Rocha L Epilepsy Res; 2019 Jan; 149():53-65. PubMed ID: 30476813 [TBL] [Abstract][Full Text] [Related]
50. New Horizons in the development of antiepileptic drugs: Innovative strategies. Löscher W; Schmidt D Epilepsy Res; 2006 Jun; 69(3):183-272. PubMed ID: 16835945 [TBL] [Abstract][Full Text] [Related]
51. Systems biology, complexity, and the impact on antiepileptic drug discovery. Margineanu DG Epilepsy Behav; 2014 Sep; 38():131-42. PubMed ID: 24090772 [TBL] [Abstract][Full Text] [Related]
52. The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81. Witkin JM; Ping X; Cerne R; Mouser C; Jin X; Hobbs J; Tiruveedhula VVNPB; Li G; Jahan R; Rashid F; Kumar Golani L; Cook JM; Smith JL Brain Res; 2019 Nov; 1722():146356. PubMed ID: 31369732 [TBL] [Abstract][Full Text] [Related]
53. New horizons in the development of antiepileptic drugs. Löscher W; Schmidt D Epilepsy Res; 2002 Jun; 50(1-2):3-16. PubMed ID: 12151112 [TBL] [Abstract][Full Text] [Related]
54. New AMPA antagonists in epilepsy. Russo E; Gitto R; Citraro R; Chimirri A; De Sarro G Expert Opin Investig Drugs; 2012 Sep; 21(9):1371-89. PubMed ID: 22788917 [TBL] [Abstract][Full Text] [Related]
55. Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development. Dichter MA Epilepsia; 1994; 35 Suppl 4():S51-7. PubMed ID: 8174519 [TBL] [Abstract][Full Text] [Related]
56. Update on the mechanisms of action of antiepileptic drugs. Sills GJ; Brodie MJ Epileptic Disord; 2001 Dec; 3(4):165-72. PubMed ID: 11844711 [TBL] [Abstract][Full Text] [Related]
57. Mechanisms of action of antiepileptic drugs. White HS; Smith MD; Wilcox KS Int Rev Neurobiol; 2007; 81():85-110. PubMed ID: 17433919 [TBL] [Abstract][Full Text] [Related]
58. The enigma of placebo effects in drug-refractory epilepsies. Krämer G Epilepsia; 2013 May; 54 Suppl 2():13-5. PubMed ID: 23646964 [TBL] [Abstract][Full Text] [Related]
59. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice. Klein S; Bankstahl M; Löscher W Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186 [TBL] [Abstract][Full Text] [Related]